Predictive Oncology Stock to Reverse Split on Tuesday, September 30th (NASDAQ:POAI)

Predictive Oncology Inc. (NASDAQ:POAI) shares are going to reverse split on Tuesday, September 30th. The 1-15 reverse split was announced on Thursday, September 25th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, September 29th.

Predictive Oncology Stock Down 19.5%

Shares of POAI stock opened at $0.95 on Friday. Predictive Oncology has a 12-month low of $0.55 and a 12-month high of $3.06. The firm has a market capitalization of $10.35 million, a price-to-earnings ratio of -0.31 and a beta of 1.37. The firm has a fifty day moving average of $0.89 and a 200-day moving average of $0.98.

Predictive Oncology (NASDAQ:POAI) last announced its quarterly earnings results on Wednesday, August 13th. The medical instruments supplier reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by ($0.13). Predictive Oncology had a negative net margin of 587.31% and a negative return on equity of 722.01%. The firm had revenue of $0.00 million during the quarter, compared to analyst estimates of $1.50 million. Research analysts expect that Predictive Oncology will post -2.08 earnings per share for the current year.

About Predictive Oncology

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.